Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2016 03:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive rapporterar positiva prekliniska resultat i NASH

Lund den 1 november 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelade idag att en av deras cyklofilinhämmare, NVP018, har...
November 01, 2016 03:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive reports positive pre-clinical results in NASH

Lund, Sweden, November 1, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced positive pre-clinical results with one of its...
October 26, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB: Årsstämma 2017 och valberedning

Lund den 26 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att årsstämma i NeuroVive Pharmaceutical AB (publ)...
October 26, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB: Annual General Meeting 2017 and Nomination Committee

Lund, Sweden, October 26, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the Annual General Meeting of NeuroVive...
October 25, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive completes closure of Lyon subsidiary

Lund, Sweden, October 25, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that it has completed the closure of its dormant...
October 25, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive fullföljer nedläggning av dotterbolag i Lyon

Lund den 25 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att bolaget har fullföljt nedläggningen av det...
October 21, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive and Arbutus sign termination agreement

Lund, Sweden, October 21, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the license agreement with Arbutus...
October 21, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive och Arbutus tecknar termineringsavtal

Lund den 21 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att licensavtalet med Arbutus Biopharma (tidigare...
October 13, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive avbryter utvecklingen av CicloMulsion för akut njurskada

Lund den 13 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), ett företag inom mitokondriell medicin, presenterar idag resultat från den explorativa kliniska fas...
October 13, 2016 02:30 ET | Source: NeuroVive Pharmaceutical AB

NeuroVive discontinues development of CicloMulsion for acute kidney injury

Lund, Sweden, October 13, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced results from the exploratory clinical phase II...